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Abstract
Background: Like all mammalian cells, normal adult chondrocytes have a limited replicative life span, which
decreases with age. To facilitate the therapeutic use of chondrocytes from older donors, a method is needed to
prolong their life span.
Methods: We transfected chondrocytes with hTERT or GRP78 and cultured them in a 3-dimensional atelocollagen
honeycomb-shaped scaffold with a membrane seal. Then, we measured the amount of nuclear DNA and
glycosaminoglycans (GAGs) and the expression level of type II collagen as markers of cell proliferation and
extracellular matrix formation, respectively, in these cultures. In addition, we allografted this tissue-engineered
cartilage into osteochondral defects in old rabbits to assess their repair activity in vivo.
Results: Our results showed different degrees of differentiation in terms of GAG content between chondrocytes
from old and young rabbits. Chondrocytes that were cotransfected with hTERT and GRP78 showed higher cellular
proliferation and expression of type II collagen than those of nontransfected chondrocytes, regardless of the age of
the cartilage donor. In addition, the in vitro growth rates of hTERT- or GRP78-transfected chondrocytes were higher
than those of nontransfected chondrocytes, regardless of donor age. In vivo, the tissue-engineered cartilage
implants exhibited strong repairing activity, maintained a chondrocyte-specific phenotype, and produced
extracellular matrix components.
Conclusions: Focal gene delivery to aged articular chondrocytes exhibited strong repairing activity and may be
therapeutically useful for articular cartilage regeneration.
Background
Osteoarthritis (OA), which is one of the most common,
debilitating, and costly chronic disorders [1], is character-
ized by progressive degeneration or destruction of articular
cartilage. Since the incidence of OA increases with age, the
underlying mechanism of this disease may involve a loss of
the capacity of chondrocytes to regenerate with age. In
proliferative cells, telomeres from chromosomes gradually
became shorter as a result of the DNA replication end
problem. To prevent cessation of mitosis and premature
cell death, telomerase is a ribonucleoprotein that is an
enzyme which adds DNA sequence repeats (TTAGGG) to
the 3’ end of DNA strands in the telomere regions, which
are found at the ends of chromosomes [2]. The telomerase
allows for replacement of short bits of DNA known as tel-
omeres, which are otherwise shortened when a cell divides
via mitosis. In normal circumstances, without the presence
of telomerase, if a cell divides recursively, at some point all
the progeny will reach their Hayflick limit. With the pre-
sence of telomerase, each dividing cell can replace the lost
bit of DNA, and any single cell can then divide
unbounded. While this unbounded growth property has
excited many researchers, caution is warranted in exploit-
ing this property, as exactly this same unbounded growth
is a crucial step in enabling cancerous growth. In immortal
human tumor cells, the gene for the catalytic subunit of
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always derepressed [3]. Moreover, hTERT is not only an
oncoprotein [2] but also a regulator of cellular differentia-
tion [4,5].
As a result, immortalized human cells, such as epithe-
lial and fibroblast cells [6] and chondrocytes [7,8], have
been used as models of cellular aging. For example,
Goldring [7] showed that primary human chondrocytes
can be immortalized with retroviral transfection of 4
genes, including simian vacuolating virus 40 large T anti-
gen and telomerase; however, stable transfection of
hTERT in chondrocytes that are cultured in a monolayer
allows maintenance of the proliferative capacity but not
the chondrocyte phenotype. In contrast, Piera-Velazquez
et al. [8] showed that exogenous expression of hTERT in
chondrocytes that are cultured on polyhydroxyethyl-
methacrylate coated dishes increases their life span and
maintains their chondrocyte phenotype. Thus, hTERT
may extend the life span of chondrocytes.
Glucose-regulated protein 78 (GRP78) is a molecular
chaperone in the endoplasmic reticulum (ER) that is
induced by ER stress and prevents cell death as a result
of homeostatic imbalance in the ER [9]. Although overex-
pression of GRP78 can limit the damage from ER stress
in normal tissues and organs, the natural induction of
GRP78 in neoplastic cells also may promote cancer pro-
gression and drug resistance [10]. Since GRP78 also is
involved in the pathology of neurological diseases, such
as Alzheimer’s disease [11] and Parkinson’s disease [12],
GRP78 may have therapeutic cytoprotective effects to
limit ER stress.
To determine whether hTERT and GRP78 can prolong
the life span of chondrocytes and stimulate cartilage
regeneration, we transfected rabbit articular chondro-
cytes with these genes and redifferentiated chondrocytes
in a 3-dimensional atelocollagen honeycomb-shaped
scaffold with a membrane seal (ACHMS scaffold) [13].
We used this type of scaffold because it is biodegradable,
supports the growth of high-density cell cultures, and
maintains the phenotype of articular chondrocytes
[14-16]. In addition, to investigate the clinical relevance
of our model to OA, we investigated whether the effects
of gene transfection depend on the age of the cartilage by
analyzing the proliferation, gross morphology, cellular
content of DNA and proteoglycans, and gene expression
level of type II collagen in the transfected chondrocytes.
Methods
Preparation of chondrocytes
All animal experiments in this study approved by
Research Support and Intellectual Property of the Uni-
versity of Tokyo were performed in accordance with
their institutional guidelines for the care and use of
laboratory animals.
Chondrocytes were prepared as described previously
[14]. Briefly, articular cartilage tissue specimens were col-
lected from the knee and shoulder joints of 4 young male
(4 weeks old, 1 kg) and 8 old female (4 years old, 4.5 kg)
Japanese white rabbits (Tokyo Laboratory Animals Science
Co., Ltd., Tokyo, Japan). Each rabbit specimen was soaked
and stored separately in basal medium (BM) containing
Dulbecco’s modified Eagle’sm e d i u m( D M E M ) / F 1 2
(Gibco; Invitrogen, Carlsbad, CA, USA) supplemented
with 10% heat-inactivated fetal bovine serum (FBS)
(Gibco), 50 μg·mL
-1 ascorbic acid (Wako Pure Chemical
Industries, Osaka, Japan), and 1% Fungizone
® antibiotic-
antimycotic solution (10,000 U·mL
-1 penicillin G,
10 mg·mL
-1 streptomycin sulfate, and 25 μg·mL
-1 ampho-
tericin B; Gibco). When needed, cartilage samples were
chopped into small pieces, and then digested for 1 h in
DMEM/F12 containing 0.4% pronase E (Kaken Pharma-
ceutical, Tokyo, Japan), followed by digestion for 3 h at
37°C in DMEM/F12 containing 0.016% collagenase P
(Roche Diagnostics, Mannheim, Germany). Subsequently,
the digested samples were filtered with a cell strainer (BD
Falcon™; BD Bioscience, Bedford, MA, USA) with a
100 μm pore size and the isolated cells were rinsed twice
with chilled Dulbecco’s calcium- and magnesium-free,
phosphate-buffered saline (PBS) (Dainippon Pharmaceuti-
cal, Osaka, Japan). The number of viable chondrocytes
was counted by using a Burker-Turk hemocytometer
(Erma, Tokyo, Japan) with Trypan blue staining. Finally,
the chondrocytes were seeded in 500 cm
2 square dishes
(245 mm × 245 mm; Corning, Corning, NY, USA) at a
density of 10,000 cells·cm
-2 and cultured in BM with 10%
FBS at 37°C in an incubator with 5% CO2.
Retroviral transfection
Retroviral transfection of cultured chondrocytes was per-
formed as described previously [17,18] with some modifi-
c a t i o n s .F i r s t ,D H 5 a Escherichia coli cells (from
Hiroshima University Graduate School of Biomedical
Sciences) were cultured overnight in lysogeny broth (LB)
media [19] at 37°C. Subsequently, these cells were trans-
fected with phTERT-MSCV and pGRP78-MSCV plasmids
to produce amphotropic viruses. The plasmids were
amplified and purified by using an EndoFree Plasmid
Maxi Kit (Qiagen, Tokyo, Japan). In addition, the sequence
of all constructs was verified by DNA sequencing.
Next, these plasmids were used to produce retroviral
constructs by using 2 different protocols. To produce
the hTERT retroviral construct, full-length hTERT
cDNA was polymerase chain reaction (PCR) amplified,
and then cloned into the pMSCV-puro retroviral vector
(Clontech, Mountain View, CA, USA). Subsequently, the
cloned vector was transfected into the Retropack PT67
(Clontech) packaging cell line and the transfected cells
were selected with puromycin (1.8 μg·mL
-1)( S i g m a
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after transfection, the surviving cells were trypsinized
and allowed to continue to grow for up to 100 d. The
culture supernatant from this cell line was collected and
0.45-μm filtered, and then polybrene (8 μg·mL
-1)w a s
added prior to transducing hTERT into young rabbit
(YRA) and old rabbit (ORA) chondrocyte cultures.
Chondrocytes were cultured and plated 24 h before
viral infection. Then, the packaged retrovirus was added
to the culture media and incubated at 37°C in an incu-
bator with 5% CO2. The infected cells were selected
with 0.5 μg·mL
-1 of puromycin (Sigma Chemical) for
7-10 d prior to subsequent experiments.
To produce the GRP78 retroviral construct, full-length
GRP78 cDNA was PCR amplified, and then inserted
into the mouse stem cell virus (MSCV) packaging vector
by using the Retrovirus Packaging Kit Ampho (TaKaRa
Biotechnology, Shiga City, Japan) [20]. To produce
GRP78-expressing retroviruses, 293 T cells (CRL-
11268™, ATCC, Manassas, VA, USA) were seeded and
maintained on 6-cm dishes at a density of 400,000
cells·cm
-2 in DMEM containing 10% FBS for 24 h prior
to transfection. Then, the culture medium was changed
to the same medium. Subsequently, the 293 T cells were
co-transfected with pGP (gag-pol) and pE-ampho (env)
(TaKaRa Biotechnology) by using calcium phosphate
transfection. Transfected cells were selected with 400
μg·mL
-1 of hygromycin (Calbiochem, La Jolla, CA, USA)
and 50 μg of mycophenolic acid (Sigma Aldrich). After
48 h, the culture medium, which contained the recombi-
nant retroviruses, was 0.45-μmf i l t e r e d ,a n dt h e nm i x e d
with DMEM to infect YRA and ORA chondrocyte
cultures.
Chondrocyte proliferation
Chondrocyte proliferation was measured by counting
cell numbers at 100% confluence in serial passages.
Briefly, nontransfected or hTERT/GRP78-transfected
YRA and ORA chondrocytes, which were passaged once
every 7-10 d, were detached by using 0.05% trypsin/
ethylenediaminetetraacetic acid (EDTA; Gibco) for 20-
30 min at 37°C and washed 3 times with PBS. An ali-
quot of the detached cells was used to count the mean
number of cells from 6 dishes by using a Burker-Turk
hemocytometer (Erma) with Trypan blue staining. The
remaining cells were replated at a density of 5 × 10
3
cells·well
-1.
Cell proliferation was expressed as the population
doubling level (PDL). The PDL was calculated from log-
phase growth curves by using the equation: PDL = log10
(N/N0) × 3.33, where N0 and N are the number of cells
at the beginning and end of each experiment, respec-
tively [21].
Preparation of the atelocollagen honeycomb-shaped
scaffold with a membrane seal and 3-dimensional culture
of chondrocytes
The ACHMS scaffold was prepared as described pre-
viously [13] by Koken (Tokyo, Japan). Briefly, nontrans-
fected and hTERT/GRP78-transfected ORA chondrocytes
were passaged twice, and then seeded at a density of 2 ×
10
6 cells·scaffold
-1 into a round ACHMS scaffold (dia-
meter, 6 mm; thickness, 2 mm; average pore size, 200 μm)
[13,14,22,23] in 48-well plates (Sumitomo Bakelite, Tokyo,
Japan) by centrifuging at 45 g for 5 min. Then, these cell-
seeded scaffolds were cultured in BM supplemented with
10% FBS at 37°C in an incubator with 5% CO2 and 100%
relative humidity for 14 d. These cultured chondrocytes
were frozen in liquid nitrogen until needed for biochem-
ical analyses and transplantation into an in vivo model of
articular cartilage defects.
Measurement of DNA and glycosaminoglycans
The amount of DNA in the cultured ORA chondrocytes,
which was used as a marker of cell proliferation, was
measured by digesting cell-seeded scaffolds with papain,
and then using a fluorimetric assay, as described pre-
viously [24]. Briefly, 15 μL of a papain digest was mixed
with 300 μL of Hoechst 33258 solution (Polyscience,
Warrington, PA, USA), and then a Titertek Multiscan
Spectrofluorometer (Lab Systems, Helsinki, Finland) was
used to measure the emission and excitation spectra at
456 nm and 365 nm, respectively. DNA concentrations
were calculated from a standard curve of calf thymus
DNA (Sigma).
The amount of glycosaminoglycans (GAGs) in the cul-
tured chondrocytes, which was used as a marker of extra-
cellular matrix (ECM) formation, was quantified by using
1,9-dimethylmethylene blue, as described previously [25].
Briefly, samples (140 μL) of each chondrocyte culture were
mixed gently with an equal volume of 1,9-dimethylmethy-
lene blue solution in a 96-well microtiter plate, and then
the absorbance at 530 nm was measured with a Titertec
multiscan spectrophotometer (Labsystem, Helsinki,
Finland). The amount of GAGs was calculated from the
absorbance values by using a standard curve of 0.625-
20 μg·mL
-1 shark chondroitin sulfate C (Seikagaku Kogyo
Co, Tokyo, Japan).
Type II collagen mRNA expression
Frozen 3-dimensional cultures of ORA chondrocytes were
pulverized with a Cryo-Press (Microtec Nition, Chiba,
Japan) in liquid nitrogen. All oligonucleotide primer sets
were designed on the basis of published mRNA sequences.
The expected amplicon lengths ranged from 70 to 200 bp.
Cloning of the entire coding region of type 2 collagen was
performed by 5’-a n d3 ’-rapid amplification of cDNA ends
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AACACTGCCAACGTCCAGAT-3’), reverse (5’-CTGC
AGCACGGTATAGGTGA-3’). Real-time PCR was per-
formed in a SmartCycler system (Cepheid, Sunnyvale, CA)
with SYBR Green PCR Master Mix (Applied Biosystems,
Foster City, CA) with 1 μLo fc D N At e m p l a t ei naf i n a l
volume of 25 μL. Amplification of cDNA was performed
according to the following conditions: 95°C for 15 s and
60°C for 60 s for 35-45 amplification cycles. Changes in
the fluorescence of SYBR Green were monitored after
every cycle. Melting curve analysis was performed through
a 0.5°C/s increase from 55 to 95°C with continuous fluor-
escence readings at the end of the cycles to ensure that
single PCR products were obtained. All reactions were
repeated in six separate PCR runs using RNA isolated
from four sets of human samples. The results were evalu-
ated by using SmartCycler software (Cepheid). Glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) primers were
used to normalize the samples. To monitor crossover con-
taminations of PCR, RNase-free water (Qiagen, Valencia,
CA) was used in the RNA extraction and as a negative
control. To ensure the quality of data, a negative control
was always included in each run.
Implantation of tissue-engineered cartilage produced
from transfected aged chondrocytes
Twenty four old female Japanese white rabbits were
divided into 4 groups (control 8w, 16w; hTERT + GRP78
8w, 16w) and anesthetized with intramuscular injections
of 120 mg of ketamine (Daiichisankyo, Tokyo, Japan) and
9 mg of xylazine (Bayer HealthCare, Leverkusen, Ger-
many). After creating a medial parapatellar incision in
both legs, each patella was dislocated laterally and a
cylindrical defect (diameter, 5 mm; depth, 3 mm) was
created on the patellar groove of the femur in both legs
by using a biopsy punch (Kai Industries, Seki, Japan) and
a low-speed drill (Takagi, Niigata, Japan). The bottom of
the subchondral bone also was shaved to a plane until
marrow bleeding was observed. Then, ACHMS scaffolds
that were seeded with either nontransfected or hTERT/
GRP78-transfected ORA chondrocytes were allografted
into these defects without any fixatives, such as fibrin
glue. Postoperatively, all animals were allowed to walk
freely in their cages without any splints.
Postoperative analyses
Eight and 16 weeks after implantation, rabbits were
killed with an overdose of intravenous anesthesia, and
then the distal parts of their femurs were harvested and
observed with a light microscope. Subsequently, the
femur samples were fixed in 10% buffered formalin for
7 d. Each specimen was decalcified with 10% EDTA in
distilled water (pH 7.4) for 3 weeks, and then embedded
in paraffin, cut into 6-μm-thick sagittal sections,
deparaffinized, and stained with safranin O (Cartilage
Staining Kit, Takara, Shiga, Japan). The histopathology
of the OA cartilage samples (n = 24) were analyzed
according to standard grading and staging of OA carti-
lage histopathology [26]. The OA score was calculated
by the following formula: OA score = most degenerated
site in the cartilage (grades 1-6, Table 1) × area of
degeneration (stages 1-4) (Table 2).
Immunohistochemical staining for type II collagen was
performed as described previously [14]. Briefly, after
deparaffinization, the sections were pretreated with
0.1 mg·mL
-1 of actinase E (Kaken Pharmaceutical) in PBS
at 37°C for 30 min. Then, the sections were incubated
w i t h1 0 %p i gs e r u ma tr o o mt e m p e r a t u r ef o r3 0m i n
to reduce nonspecific background staining. These pre-
treated sections were incubated overnight with
50 mg·mL
-1 mouse anti-human type II collagen monoclo-
nal antibody (Daiichi Fine Chemical, Toyama, Japan) in
PBS containing 0.1% bovine serum albumin at 4°C. Next,
the sections were incubated with biotinylated rabbit anti-
mouse immunoglobulin (1:500 dilution; Dako, Carpin-
teria, CA, USA) for 30 min at room temperature, fol-
lowed by peroxidase-conjugated streptavidin (1:500
dilution; Dako) for 30 min at room temperature. Finally,
the sections were incubated with a solution of 20 mg of
diaminobenzidine and 5 μL of hydrogen peroxide (30%)
i n1 0 0m Lo fP B Sf o r5m i na tr o o mt e m p e r a t u r e .C o n -
trol sections were incubated with PBS without any anti-
bodies and stained in a similar manner. These sections
were analyzed by light microscopy.
Statistical analysis
One-way analysis of variance and Dunn’s post hoc test
was used to determine statistical significance (P < 0.05).
Results
Establishment of primary cultures of rabbit chondrocytes
During the first 3 weeks, YRA, ORA, ORA + hTERT,a n d
ORA + hTERT + GRP78 chondrocytes showed similar
growth rates for 10 PDL (Figure 1). Later, ORA + hTERT
and ORA + hTERT + GRP78 chondrocytes proliferated
more rapidly than the nontransfected chondrocytes.
However, YRA + hTERT + GRP78 chondrocytes had the
fastest growth rate. In the control groups, YRA chondro-
cytes proliferated faster than ORA chondrocytes during
the entire observation period, but their growth rate gra-
dually decreased until they ceased at about 40 d and 60 d
after the initiation of culture, respectively. Unlike control
cells, which stopped proliferating after 10-20 PDL, ORA
+ hTERT and YRA + hTERT cells continued proliferating
for about 35 and 50 PDL, respectively. These results
showed that hTERT and GRP78 increase the growth rate
of transfected cells approximately 3-fold compared with
nontransfected cells.
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chondrocytes
The ACHMS scaffold supported a high density of ORA
chondrocytes (2 × 10
6 cells·cm
-2) without any leakage of
cells. During the 2-week culture, the chondrocytes in the
scaffold retained their normal spherical shape (data not
shown) and the resulting tissue-engineered cartilage main-
tained its shape and size in the ACHMS scaffold. The scaf-
folds were elastic and did not deform during culturing or
collapse when handled with forceps.
Figure 2 shows macroscopic images of the cell-seeded
scaffolds after culturing for 14 d. The scaffold that was
seeded with hTERT/GRP78-transfected ORA chondro-
cytes had the highest cell density. In addition, the spaces
between the atelocollagen matrix were filled and not visi-
ble along the edge of the ACHMS scaffold, which indi-
cated that chondrocytes had proliferated throughout the
scaffold during the cultivation period. In the scaffolds that
were seeded with control cells, cell growth was sparse, and
as a result, the spaces between the atelocollagen matrix
remained mostly empty.
Glycosaminoglycan content of cell-seeded scaffolds
On day 14, the amount of GAG in cell-seeded scaffolds
differed significantly between each group (Figure 3). Speci-
fically, the total GAG content of scaffolds that were seeded
with hTERT/GRP78-transfected ORA chondrocytes was
higher than those that were seeded with GRP78-o r
hTERT-transfected cells. In addition, the GAG content of
the scaffolds that were seeded with transfected ORA chon-
drocytes was higher than that in those that were seeded
with nontransfected chondrocytes. These results suggested
that transfected ORA chondrocytes were able to produce
and accumulate significantly higher amounts of extracellu-
lar matrix components in the ACHMS scaffold than non-
transfected chondrocytes.
Table 1 OA cartilage histopathology grade assessment; grading methodology
Grade (key feature) Associated criteria (tissue reaction)
Grade 1: surface intact Matrix: superficial zone intact, oedema and/or superficial fibrillation (abrasion), focal superficial matrix condensation
Cells: death, proliferation (clusters), hypertrophy, superficial zone Reaction must be more than superficial fibrillation only
Grade 2: surface
discontinuity
As above
+ Matrix discontinuity at superficial zone (deep fibrillation)
± Cationic stain matrix depletion (Safranin O or Toluidine Blue) upper 1/3 of cartilage
± Focal perichondronal increased stain (mid zone)
± Disorientation of chondron columns
Cells: death, proliferation (clusters), hypertrophy
Grade 3: vertical fissures
(clefts)
As above
Matrix vertical fissures into mid zone, branched fissures
± Cationic stain depletion (Safranin O or Toluidine Blue) into lower 2/3 of cartilage (deep zone)
± New collagen formation (polarized light microscopy, Picro Sirius Red stain)
Cells: death, regeneration (clusters), hypertrophy, cartilage domains adjacent to fissures
Grade 4: erosion Cartilage matrix loss: delamination of superficial layer, mid layer cyst formation
Excavation: matrix loss superficial layer and mid zone
Grade 5: denudation Surface: sclerotic bone or reparative tissue including fibrocartilage within denuded surface. Microfracture with repair
limited to bone surface
Grade 6: deformation Bone remodelling (more than osteophyte formation only). Includes: microfracturewith fibrocartilaginous and osseous
repair extending above the previous surface
Grade = depth progression into cartilage
Table 2 OA score; semi-quantitative method
Grade (key feature) Stage % Involvement (surface, area, volume)
Stage 1 < 10% Stage 2 10-25% Stage 3 25-50% Stage 4 > 50%
Grade 1(surface
intact)
12 34
Grade 2 (surface
discontinuity)
24 68
Grade 3 (vertical
fissures, clefts)
36 9 1 2
Grade 4 (erosion) 4 8 12 16
Grade 5(denudation) 5 10 15 20
Grade 6(deformation) 6 12 18 24
Score = grade × stage
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As shown in Figure 4, the mRNA expression of type II
collagen was observed in ORA, regardless of different
gene transfection. Profiles of control, GRP78
+, hTERT
+,
and hTERT
+/GRP78
+ cells were prepared to investigate
expression of type II collagen. The mRNA expressions
of GRP78
+, hTERT
+,a n dhTERT
+/GRP78
+ cells were
significantly higher than that in control of non-transfec-
tive ORA. Chondrocytes are known to readily dediffer-
enciate in 2-dimensional culture. However, in this study,
we used the primary culture of chondrocytes so that
these chondrocytes retain their phenotype, which can be
confirmed from type II collagen expression.
Macroscopic appearance of repaired osteochondral
defects
The surgical implantation of tissue-engineered cartilage
into osteochondral defects in the old rabbits was
uneventful, and upon waking, all rabbits immediately
resumed normal cage activity. At the time that they
were killed, all rabbits exhibited unlimited passive range
of motion in the knee joint.
Indeed, the osteochondral defects in old rabbits that
were treated with tissue-engineered cartilage that was
Figure 1 Effect of hTERT and GRP78 on the proliferation of
rabbit chondrocytes. Growth curves of cultures of nontransfected
control chondrocytes from young and old rabbits (YRA and ORA,
respectively) and hTERT (YRA + hTERT and ORA + hTERT) and GRP78
(YRA + hTERT + GRP78 and ORA + hTERT + GRP78)-transfected
chondrocytes. The mean number of cells is shown on a log10 scale.
Figure 2 Macroscopic images of the cell-scaffold complex after
14 days of culture. Atelocollagen honeycomb-shaped scaffold with
a membrane seal (ACHMS) scaffold complex seeded with
nontransfected (A), GRP78-transfected (B), hTERT-transfected (C), or
hTERT- and GRP78-transfected (D) ORA chondrocytes. Scale bar = 1.0
mm.
Figure 3 Glycosaminoglycan content of chondrocyte cultures in
atelocollagen honeycomb-shaped scaffolds with a membrane
seal. The glycosaminoglycan (GAG) content of nontransfected (black
bars) or hTERT-o rGRP78-transfected (white bars) ORA chondrocytes
on the indicated days. Results are expressed as the mean (SD) of 6
independent measurements. *P < 0.05.
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drocytes were filled with smooth tissue that resembled
hyaline cartilage 16 weeks after surgery (Figure 5E) unlike
the tissue-engineered cartilage that was grown from non-
transfected ORA chondrocytes, which remained empty
or were covered by fibrous tissue (Figure 5B). Although
the control tissue-engineered cartilage showed some tis-
sue repair along the borders of the defect, the color of
t h et i s s u ew a ss l i g h t l yd i f f e r e n tf r o mt h a to ft h es u r -
rounding normal cartilage (Figure 5A, B).
Histological analysis of repaired osteochondral defects
No signs of arthritis, such as cartilage erosion or severe
synovial proliferation, were observed in any surgically
treated knee. In rabbits that were implanted with tissue-
engineered cartilage grown from hTERT-a n dGRP78-
transfected ORA chondrocytes, the immunohistochem-
ical staining for type II collagen in the extracellular
matrix in the scaffold was more intense and covered a
larger area (Figure 5F) than those that were implanted
with scaffolds that were grown from nontransfected ORA
chondrocytes (Figure 5C). In addition, the tissue-engi-
neered cartilage that was grown from transfected ORA
chondrocytes was smooth and displayed good bonding
with the host cartilage on both sides. In contrast, the tis-
sue-engineered cartilage that was grown from nontrans-
fected ORA chondrocytes had an irregular surface and
was thinner than that grown from hTERT-a n dGRP78-
transfected chondrocytes (Figure 5C).
As shown in Figure 6, the average OA scores were as
follows: control 8w, 11.2 (2.5); 16w, 16.0 (3.2); hTERT +
GRP78 8w, 17.3 (3.5); 16w, 21.00 (2.85). Statistically sig-
nificant differences (P < 0.05) were observed between
the transfected and nontransfected groups that were
observed for the same period of time after implantation.
Discussion
Aging is the most important risk factor for both the
initiation and progression of degenerative cartilage dis-
eases. Osteoarthritic cartilage degeneration may be due
to the loss of viable chondrocytes due to apoptosis or
physical stress. This degeneration is likely to be closely
related to age-related changes, since aging chondrocytes
and articular cartilage matrix undergo senescence-like
changes, which increase the susceptibility of cells to
degenerative processes and environmental or physiologi-
cal stresses [27]. As a result, chondrocytes from osteoar-
thritic patients might progress toward senescence more
rapidly than those from normal individuals.
Aging chondrocytes also have important therapeutic
ramifications. Recently, the treatment of articular cartilage
defects have improved with the introduction of advanced
tissue engineering techniques for autologous chondrocyte
implantation (ACI) [28]. ACI requires cell expansion in
culture to provide sufficient amounts of chondrocytes for
reimplantation. However, like all mammalian cells, normal
adult chondrocytes have a limited mitotic potential and
eventually enter a state of senescence [29]. Moreover, the
Figure 4 mRNA expression levels of type II collagen in
transfected chondrocytes. The mRNA expression of type II collagen
was observed in ORA, regardless of different gene transfection.
Profiles of control, GRP78
+, hTERT
+, and hTERT
+/GRP78
+ cells were
prepared to investigate expression of type II collagen. The mRNA
expressions of GRP78
+, hTERT
+, and hTERT
+/GRP78
+ cells were
significantly higher than that in control of non-transfective ORA.
GAPDH was used as an internal control to normalize RNA levels.
Figure 5 Macroscopic and immunostaining of regenerated
cartilage after implantation. Postoperative appearance of repaired
osteochondral defects in old rabbits implanted with scaffolds
seeded with either nontransfected (top panels) or hTERT- and
GRP78-transfected ORA chondrocytes (bottom panels) either 8 (A, D)
or 16 (B, E) weeks after surgery. Immunostaining of type II collagen
in tissue sections from rabbits implanted with scaffolds seeded with
nontransfected (C) or hTERT- and GRP78-transfected (F) ORA
chondrocytes. Each micrograph is representative of 8 tissue samples.
Scale bar = 1.0 mm.
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by the age of the donor, such that cells from older donors
have a shorter life spans than those from younger donors
[30]. For example, in monolayer cultures of aged human
chondrocytes, serial passages rapidly results in loss of phe-
notypic stability and proliferative capacity [7]. Thus, to
facilitate the therapeutic use of chondrocytes from older
donors, a method is needed to prolong their replicative life
span.
O n ep o s s i b l em e t h o di st r a n s f e c t i o no fhTERT,w h i c h
can immortalize or prolong the life span of various human
cells, such as muscle satellite cells [31,32], myoblasts
[33,34], fibroblasts [6], and chondrocytes [7,8]. Since most
immortalized cells maintain their phenotype and state of
differentiation, hTERT-transfected cells are considered
potential therapies for small-cell lung cancer [35] and for
postnatal neovascularization in severe ischemic disease
[36]. However, since chondrocytes uniquely maintain their
phenotypes in 3-dimensional cultures [37], it is not known
whether hTERT-immortalized chondrocytes maintain
their state of differentiation.
Due to the aforementioned issues, in most cartilage
tissue engineering studies, donor chondrocytes are
usually from young animals. Our study is the first report
that transfection of hTERT and GRP78 can increase the
replicative life span and therapeutic potential of tissue-
engineered cartilage that is produced from ORA chon-
drocytes, which have a limited regenerative capacity. In
addition, we used an ACHMS scaffold to maintain the
phenotype of transfected chondrocytes, as indicated by
the production of GAGs and type II collagen (Figures 3
and 4). These results are consistent with the findings of
Piera-Velazquez et al. [8].
In this study, we overcame the limited lifespan of ORA
chondrocytes by transfection with hTERT and increased
their growth rate up to 3-fold by cotransfection with
GRP78 (Figure 1). Specifically, hTERT/GRP78-transfected
ORA chondrocytes grew at a constant rate for more than
20 PDL, whereas nontransfected chondrocytes stopped
dividing after much fewer PDL. However, we were not
able to completely immortalize chondrocytes, even those
from young rabbits (PDL < 50). Although the additional
transfection of SV40-TAg or mutant Ras could immorta-
lize these cells, we did not choose this option because the
transfected cells may have become cancerous. As a result,
we focused on the phenotypic stability of GRP78 and
hTERT.
hTERT is a candidate gene for gene therapy of muscu-
lar dystrophy [31-34]. In contrast, GRP78 may have ther-
apeutic applications for neuropathological conditions,
such as Alzheimer’s disease, because it protects cells
from ER stress [11,38-40]. ER stress can alter protein
synthesis in cells [41]. One mechanism by which ER
stress promotes apoptosis in cells is by driving the accu-
mulation of structurally abnormal proteins [42], which
are ordinarily repaired by ER chaperones to prevent age-
related cell death. GRP78 is an example of a chaperone
protein that regulates protein folding in the ER and thus
contributes to cell survival [43]. Since the increase in the
expression of GRP78 during cell culture may help protect
cells from ER stress, overexpression of GRP78 also may
protect cultured chondrocytes independent of hTERT.
Due to a lack of cages for mutant rabbits, we were not
able to perform animal transplantation experiments with
chondrocytes that were transfected with hTERT or
GRP78 alone. However, we believe that our in vitro and
in vivo results from chondrocytes that were transfected
with both hTERT and GRP78 are sufficient to support
our conclusions. In the future, we plan to perform more
animal experiments to elucidate the effects of GRP78.
In conclusion, our results showed that tissue-engineered
cartilage that was grown from implanted in vivo with
hTERT-a n dGRP78-transfected ORA chondrocytes in
ACHMS scaffolds can repair articular cartilage defects in
vivo (Figure 5D, E, F). The hTERT and GRP78-transfected
ORA exhibited proliferative and differentiation activity in
articular cartilage defects, resulting in the formation of
hyaline cartilage. This study also shows that ORA chon-
drocytes potentially produce hyaline cartilage after genetic
treatment, similar to chondrocytes from young animals.
Figure 6 Osteoarthritis score. The histopathology of the OA
cartilage samples from all 4 groups (n = 24) were analyzed
according to standard grading and staging of OA cartilage
histopathology. OA scores were calculated by using the following
formula: OA score = most degenerated site in the cartilage (grades
1-6, Table 1) × area of degeneration (stages 1-4) (Table 2). Error bars
indicate the standard deviation of each group. Statistically
significant differences were observed between the control and
hTERT + GRP78 groups 8 and 16 weeks after transplantation.
Sato et al. BMC Musculoskeletal Disorders 2012, 13:51
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Page 8 of 10However, the mechanical strength of regenerated articular
cartilage in large animals (i.e., sheep or pigs) needs to be
investigated.
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